BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3721789)

  • 1. Fluorescein and fluorescein glucuronide pharmacokinetics after intravenous injection.
    Blair NP; Evans MA; Lesar TS; Zeimer RC
    Invest Ophthalmol Vis Sci; 1986 Jul; 27(7):1107-14. PubMed ID: 3721789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of fluorescein after intravenous administration.
    Chahal PS; Neal MJ; Kohner EM
    Invest Ophthalmol Vis Sci; 1985 May; 26(5):764-8. PubMed ID: 3997424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma fluorescein and fluorescein glucuronide in patients with selected eye diseases.
    Blair NP; Evans MA; Lesar TS; Willett M
    Graefes Arch Clin Exp Ophthalmol; 1989; 227(2):114-7. PubMed ID: 2721978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular pharmacokinetics in rabbits using a novel dual probe microdialysis technique.
    Macha S; Mitra AK
    Exp Eye Res; 2001 Mar; 72(3):289-99. PubMed ID: 11180978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular fluorometry methodological improvements and clinical studies--with special reference to the blood-retina barrier permeability to fluorescein and fluorescein glucuronide.
    Larsen M
    Acta Ophthalmol Suppl (1985); 1993; (211):1-52. PubMed ID: 8318868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of fluorescein and fluorescein monoglucuronide in the living human eye.
    McLaren JW; Brubaker RF
    Invest Ophthalmol Vis Sci; 1986 Jun; 27(6):966-74. PubMed ID: 3710736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescein and fluorescein glucuronide in the vitreous body of diabetic patients.
    Lund-Andersen H; Larsen M; Dalgaard P; Olsen W
    Graefes Arch Clin Exp Ophthalmol; 1987; 225(3):173-6. PubMed ID: 3609757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of fluorescein in the vitreous.
    Palestine AG; Brubaker RF
    Invest Ophthalmol Vis Sci; 1981 Oct; 21(4):542-9. PubMed ID: 7287343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of fluorescein glucuronide and its metabolism in vitreous fluorophotometry.
    Plehwe WE; Chahal PS; Fallon TJ; Cunningham JR; Neal MJ; Kohner EM
    Exp Eye Res; 1987 Feb; 44(2):209-15. PubMed ID: 3582508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular fluorophotometry using high S-N ratio fluorophotometer.
    Kayazawa F
    Ann Ophthalmol; 1984 May; 16(5):472-6. PubMed ID: 6742687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescein and fluorescein glucuronide in plasma after intravenous injection of fluorescein.
    Larsen M; Loft S; Hommel E; Lund-Andersen H
    Acta Ophthalmol (Copenh); 1988 Aug; 66(4):427-32. PubMed ID: 3195322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of the permeability of the blood-retinal barrier in normal individuals.
    Oguro Y; Tsukahara Y; Saito I; Kondo T
    Invest Ophthalmol Vis Sci; 1985 Jul; 26(7):969-76. PubMed ID: 4008211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of blood-retinal barrier permeability: a reproducibility study in normal eyes.
    Chahal PS; Chowienczyk PJ; Kohner EM
    Invest Ophthalmol Vis Sci; 1985 Jul; 26(7):977-82. PubMed ID: 4008212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypotony and aqueous humor dynamics in myotonic dystrophy.
    Walker SD; Brubaker RF; Nagataki S
    Invest Ophthalmol Vis Sci; 1982 Jun; 22(6):744-51. PubMed ID: 7076420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of aqueous humor flow determination by fluorophotometry.
    Pederson JE; Gaasterland DE; MacLellan HM
    Invest Ophthalmol Vis Sci; 1978 Feb; 17(2):190-5. PubMed ID: 415021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular hypotensive mechanism of intravitreally injected brain natriuretic peptide in rabbit.
    Takashima Y; Taniguchi T; Yoshida M; Haque MS; Yoshimura N; Honda Y
    Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2671-7. PubMed ID: 8977481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescein distribution in retinas of normal and diabetic rats.
    Grimes PA
    Exp Eye Res; 1985 Aug; 41(2):227-38. PubMed ID: 4065247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics of a new antiglaucoma drug, latanoprost, in the rabbit.
    Sjöquist B; Basu S; Byding P; Bergh K; Stjernschantz J
    Drug Metab Dispos; 1998 Aug; 26(8):745-54. PubMed ID: 9698288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human corneal endothelial permeability to fluorescein and fluorescein glucuronide.
    Seto C; Araie M; Sawa M; Takase M
    Invest Ophthalmol Vis Sci; 1987 Sep; 28(9):1457-63. PubMed ID: 3623832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescein glucuronide: can this metabolite interfere with fluorescein tracer studies?
    Grotte D; Mattox V; Brubaker RF
    Trans Am Ophthalmol Soc; 1983; 81():125-9. PubMed ID: 6676965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.